Second, as the association between DRD2 Taq1A polymorphism and PD-related clinical symptoms was not determined in our study, the association between the morphological changes caused by Taq1A polymorphism and behavioral performance remains unclear. This evidence concerns the gene DRD2 and Parkinson disease.